glp-1 latest use tripled among non-diabetics, reaching $5.8B in 2022 Designed to help manage daily cravings and promote mindful habits Retatrutide for weight loss: Study

Plaintiffs allege these medications can cause gastroparesis and other gastrointestinal injuries, while Eli Lilly and Novo Nordisk deny the allegations

[DOI] [PMC free article] [PubMed] 101.Romero-Gmez M, et al

PMID: 32229443

Analysis of SDC2 gene promoter methylation in whole blood for noninvasive early detection of colorectal cancer

Similar effects have been observed on eating control, sweet cravings, and symptoms of food addiction [147,[150], [151], [152], [153]]

The identification of a mechanistically informed acceptable and safe therapeutic capable of reducing craving, withdrawal, hyperphagia and post-cigarette smoking cessation weight gain would be potentially very impactful in subpopulations as well as the general population